Products

Midostar 25mg Capsules – Midostaurin | Acute Myeloid Leukemia Treatment | Global Supplier & Exporter Midostar 25mg Capsules contain Midostaurin, a targeted anti-cancer medication used in the treatment of Acute Myeloid Leukemia (AML) with FLT3 mutation and systemic mastocytosis. Midostaurin belongs to a class of medicines known as kinase inhibitors, which block specific proteins responsible for cancer cell growth and survival. Midostar works by inhibiting abnormal signals in cancer cells that promote their growth and division. By blocking these signals, the medicine helps slow the progression of leukemia and supports improved treatment outcomes when used alongside chemotherapy. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Midostar 25mg Capsules to hospitals, oncology clinics, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Midostar 25mg Capsules Generic Name: Midostaurin Strength: 25 mg Form: Capsules Drug Class: Kinase Inhibitor (FLT3 Inhibitor) Manufacturer: Natco Pharma Ltd. Packaging: Bottle / Blister Pack Route of Administration: Oral Mechanism of Action Midostar contains Midostaurin, which blocks several protein kinases including FLT3 (FMS-like Tyrosine Kinase 3) that play a critical role in the growth of leukemia cells. By inhibiting these kinases, the drug slows cancer cell proliferation and promotes cancer cell death. Uses of Midostar 25mg Capsules Midostar Capsules are used in the treatment of: Acute Myeloid Leukemia (FLT3 mutation positive) Advanced Systemic Mastocytosis Aggressive Systemic Mastocytosis Mast Cell Leukemia Benefits Targeted therapy for leukemia Blocks FLT3 mutation activity in AML Helps slow cancer progression Used with chemotherapy for improved outcomes Effective treatment for systemic mastocytosis Dosage & Administration Midostar 25mg Capsules are taken orally as prescribed by a qualified oncologist. The dosage and duration of treatment depend on the patient’s medical condition, response to therapy, and treatment protocol. Possible Side Effects Some patients may experience: Nausea and vomiting Fatigue Fever Low blood cell counts Diarrhea Patients should be monitored regularly during treatment. Storage Instructions Store in a cool and dry place Keep away from moisture and heat Keep out of reach of children Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and distributor of oncology and specialty medicines. We supply genuine pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Genuine oncology medicines GMP certified pharmaceutical sourcing Competitive wholesale pricing Reliable global shipping (DHL / Aramex / FedEx) Export documentation including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Dargen 25mg (Darbepoetin Alfa) Injection – Global Supplier & Exporter | Ernest Oncology Dargen 25mg Darbepoetin Alfa Injection – Treatment for Anemia in Cancer & Chronic Kidney Disease Dargen 25mg Injection (Darbepoetin Alfa) is an advanced erythropoiesis-stimulating agent (ESA) used to treat anemia caused by chemotherapy in cancer patients and chronic kidney disease (CKD). Darbepoetin alfa helps stimulate the bone marrow to produce red blood cells, improving oxygen supply in the body and reducing fatigue associated with anemia. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Dargen 25mg (Darbepoetin Alfa) Injection to oncology hospitals, dialysis centers, healthcare institutions, and pharmaceutical distributors across major international healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica.What is Dargen 25mg (Darbepoetin Alfa) Injection? Dargen 25 mg contains Darbepoetin Alfa, a synthetic form of erythropoietin, a hormone that stimulates the production of red blood cells in the bone marrow. Patients undergoing chemotherapy or those suffering from chronic kidney disease often experience anemia due to reduced red blood cell production. Darbepoetin alfa helps correct this deficiency by promoting red blood cell formation. This medication is widely used in oncology and nephrology treatment protocols worldwide. Mechanism of Action Darbepoetin alfa works by stimulating erythropoietin receptors in the bone marrow, promoting red blood cell production. Its therapeutic actions include: • Stimulating erythropoiesis (red blood cell formation) • Increasing hemoglobin levels in patients with anemia • Reducing need for blood transfusions • Improving oxygen delivery to body tissues These mechanisms help improve quality of life for patients undergoing chemotherapy or dialysis treatments.Medical Uses of Dargen 25mg Injection Doctors prescribe Dargen (Darbepoetin Alfa) for several medical conditions: Chemotherapy-Induced Anemia Helps treat anemia in cancer patients receiving chemotherapy. Chronic Kidney Disease (CKD) Used in dialysis and non-dialysis CKD patients to treat anemia. Anemia Management in Oncology Patients Helps maintain hemoglobin levels during cancer treatment. Supportive Therapy in Cancer Care Improves patient strength and reduces fatigue associated with anemia. Benefits of Dargen 25mg (Darbepoetin Alfa) Injection • Effective treatment for chemotherapy-induced anemia • Stimulates natural red blood cell production • Reduces the need for blood transfusions • Helps improve patient energy and quality of life • Widely recommended in oncology and nephrology guidelines Product Information Product Name: Dargen Injection Generic Name: Darbepoetin Alfa Strength: 25 mcg Dosage Form: Injection Therapeutic Class: Erythropoiesis-Stimulating Agent (ESA) Indication: Anemia due to chemotherapy and chronic kidney disease Prescription: Required Global Demand for Darbepoetin Alfa Injection With increasing global cases of chronic kidney disease and cancer treatments requiring chemotherapy, demand for Darbepoetin alfa injections continues to rise. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Darbepoetin alfa injections from reliable pharmaceutical exporters in India, such as Ernest Oncology. Dargen 25mg Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology and specialty medicines from India. The company supplies medicines to: • Oncology hospitals • Dialysis centers • Cancer treatment institutes • Pharmaceutical wholesalers • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global supply network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging and cold-chain handling • Fast worldwide delivery through reliable logistics partners • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides full pharmaceutical export documentation, including • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383🔗 WhatsApp Direct Link https://wa.me/919359902383

Hamsyl 3750 IU Injection – Ulinastatin | Acute Pancreatitis & Sepsis Treatment | Global Supplier & Exporter Hamsyl 3750 IU Injection contains Ulinastatin, a protease inhibitor used in the treatment of acute pancreatitis, sepsis, systemic inflammatory conditions, and shock. It works by inhibiting harmful enzymes and inflammatory mediators that damage tissues during severe infections and inflammatory responses. Hamsyl Injection helps reduce inflammation, protect organs, and improve recovery in critically ill patients. It is widely used in intensive care units (ICU) for managing severe inflammatory conditions and complications related to infections. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Hamsyl 3750 IU Injection to hospitals, healthcare institutions, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Hamsyl 3750 IU Injection Generic Name: Ulinastatin Strength: 3750 IU Form: Injection / Vial Drug Class: Protease Inhibitor Manufacturer: Samarth Life Sciences Pvt. Ltd. Packaging: 1 Vial Route of Administration: Intravenous Injection / Infusion Mechanism of Action Hamsyl contains Ulinastatin, a protease inhibitor that blocks the activity of inflammatory enzymes such as trypsin, elastase, and other proteases. By inhibiting these enzymes, the medicine reduces inflammation, protects organs from damage, and helps stabilize the patient during severe infections and inflammatory responses. Uses of Hamsyl 3750 IU Injection Hamsyl Injection is used in the treatment of: Acute Pancreatitis Sepsis and severe infections Systemic inflammatory response syndrome (SIRS) Septic shock Post-surgical inflammatory complications Organ protection in critical illness Benefits Reduces inflammation in severe conditions Protects organs during sepsis and pancreatitis Improves recovery in critically ill patients Helps control excessive enzyme activity Widely used in ICU and emergency care Dosage & Administration Hamsyl 3750 IU Injection is administered by intravenous injection or infusion under the supervision of a qualified healthcare professional in a hospital setting. The dosage depends on the patient’s condition and severity of illness. Possible Side Effects Some patients may experience: Allergic reactions Nausea Injection site reactions Headache Skin rash Medical monitoring is recommended during treatment. Storage Instructions Store in a cool and dry place Protect from light Keep out of reach of children Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and supplier of specialty and critical care medicines. We provide genuine pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Genuine pharmaceutical products GMP certified sourcing Competitive wholesale pricing Fast worldwide shipping (DHL / Aramex / FedEx) Export documentation, including COA, MSDS, invoice, and Packing List 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Erbitux 100mg Injection – Cetuximab | Targeted Therapy for Colorectal & Head Neck Cancer | Global Supplier & Exporter Erbitux 100mg Injection contains Cetuximab, a monoclonal antibody used in targeted cancer therapy for the treatment of metastatic colorectal cancer and head & neck cancer. It works by binding to the epidermal growth factor receptor (EGFR) on cancer cells, blocking signals that promote tumor growth and cell division. Erbitux is commonly used either alone or in combination with chemotherapy or radiation therapy to improve treatment outcomes in patients with EGFR-expressing cancers. By targeting cancer cells specifically, this therapy helps slow tumor progression and supports better disease control. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Erbitux 100mg Injection to hospitals, oncology clinics, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Erbitux 100mg Injection Generic Name: Cetuximab Strength: 100 mg Form: Injection / Vial Drug Class: Monoclonal Antibody (EGFR Inhibitor) Manufacturer: Merck KGaA Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Erbitux contains Cetuximab, which targets and binds to the Epidermal Growth Factor Receptor (EGFR) on the surface of cancer cells. By blocking EGFR activation, it prevents cancer cells from growing, dividing, and spreading, thereby slowing tumor progression. Uses of Erbitux 100mg Injection Erbitux Injection is used for the treatment of: Metastatic Colorectal Cancer (mCRC) Head and Neck Squamous Cell Carcinoma (HNSCC) EGFR-expressing tumors Benefits Targeted monoclonal antibody therapy Blocks EGFR signaling in cancer cells Slows tumor growth and spread Used in combination with chemotherapy or radiation Improves treatment outcomes in advanced cancers Dosage & Administration Erbitux 100mg Injection is administered through intravenous infusion by a trained healthcare professional in a hospital or oncology clinic. The dosage and treatment schedule are determined by the patient’s body weight and treatment protocol. Possible Side Effects Some patients may experience: Skin rash Infusion reactions Fatigue Nausea Diarrhea Patients should be monitored during treatment to manage possible side effects. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and distributor of oncology medicines. We supply genuine pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Trusted oncology medicine exporter from India GMP certified pharmaceutical sourcing Competitive wholesale pricing Reliable international shipping (DHL / Aramex / FedEx) Export documentation including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Vectibix 100mg Injection – Panitumumab | Targeted Therapy for Colorectal Cancer | Global Supplier & Exporter Vectibix 100mg Injection contains Panitumumab, a monoclonal antibody used as targeted therapy for the treatment of metastatic colorectal cancer (mCRC). It works by binding to the epidermal growth factor receptor (EGFR) on cancer cells, blocking signals that promote tumor growth and spread. Vectibix is commonly prescribed for patients with RAS wild-type metastatic colorectal cancer who have not responded to standard chemotherapy treatments. By targeting EGFR, the medication helps slow cancer progression and improve treatment outcomes. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Vectibix 100mg Injection to hospitals, oncology clinics, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Vectibix 100mg Injection Generic Name: Panitumumab Strength: 100 mg Form: Injection / Vial Drug Class: Monoclonal Antibody (EGFR Inhibitor) Manufacturer: Amgen Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Vectibix contains Panitumumab, a fully human monoclonal antibody that targets EGFR (Epidermal Growth Factor Receptor) on the surface of cancer cells. By blocking EGFR signaling, the medicine prevents cancer cell growth, division, and survival, thereby slowing the progression of colorectal cancer. Uses of Vectibix 100mg Injection Vectibix Injection is primarily used in the treatment of: Metastatic Colorectal Cancer (mCRC) EGFR-expressing colorectal tumors RAS wild-type colorectal cancer patients Benefits Targeted monoclonal antibody therapy Specifically blocks EGFR signaling in cancer cells Slows tumor growth and progression Effective in advanced colorectal cancer Improves treatment response in selected patients Dosage & Administration Vectibix 100mg Injection is administered by intravenous infusion under the supervision of a qualified healthcare professional in a hospital or oncology center. The dosage and frequency are determined by the patient’s body weight and treatment protocol. Possible Side Effects Some patients may experience: Skin rash Diarrhea Fatigue Nausea Infusion-related reactions Medical monitoring is recommended during treatment to manage possible side effects. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and supplier of oncology and specialty medicines. We supply authentic pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Genuine oncology medicines GMP certified pharmaceutical sourcing Competitive wholesale pricing Reliable worldwide shipping (DHL / Aramex / FedEx) Export documents including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Belustine 40mg (Lomustine) Capsule – Global Supplier & Exporter | Ernest Oncology Belustine 40mg Lomustine Capsules – Chemotherapy Medicine for Brain Tumors & Hodgkin’s Lymphoma Belustine 40mg Capsule (Lomustine) is a potent chemotherapy medicine used in the treatment of brain tumors, Hodgkin’s lymphoma, and other malignant cancers. Lomustine belongs to the class of medicines known as alkylating agents, which work by damaging the DNA of cancer cells and preventing them from multiplying. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Belustine 40mg (Lomustine) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Belustine 40mg (Lomustine) Capsule? Belustine 40mg contains Lomustine, an oral chemotherapy drug widely used in brain tumor treatment and lymphoma therapy. Lomustine is capable of crossing the blood–brain barrier, making it particularly effective for treating cancers of the brain and central nervous system. This medicine interferes with DNA replication in cancer cells, helping stop tumor growth and spread. Lomustine therapy is frequently included in oncology treatment protocols for brain cancers and lymphatic malignancies. Mechanism of Action Lomustine works by alkylating DNA strands inside cancer cells, which prevents the cells from dividing and multiplying. Key therapeutic actions include: • Damaging cancer cell DNA • Preventing tumor cell replication • Blocking cell division in malignant tissues • Inducing apoptosis (programmed cancer cell death) These mechanisms help slow or stop the progression of aggressive cancers such as brain tumors and lymphomas. Medical Uses of Belustine 40mg Capsule Doctors prescribe Belustine (Lomustine) for several cancer treatment protocols: Brain Tumors Used for treatment of primary brain tumors and metastatic brain cancers. Hodgkin’s Lymphoma Often included in combination chemotherapy regimens for Hodgkin’s lymphoma. Non-Hodgkin’s Lymphoma Helps treat certain types of lymphatic cancers. Gliomas and CNS Tumors Effective in treatment of gliomas and other central nervous system tumors. Benefits of Belustine 40mg (Lomustine) Capsule • Effective chemotherapy for brain tumors • Capable of crossing the blood–brain barrier • Helps slow tumor growth and progression • Oral capsule treatment for convenient administration • Recommended in international oncology treatment guidelines Product Information Product Name: Belustine Capsule Generic Name: Lomustine Strength: 40 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Alkylating Agent Indication: Brain Tumors, Hodgkin’s Lymphoma, CNS Tumors Prescription: Required Global Demand for Lomustine Capsules With the increasing global incidence of brain tumors and lymphatic cancers, demand for Lomustine chemotherapy medicines continues to grow. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Lomustine capsules from trusted pharmaceutical exporters in India, such as Ernest Oncology. Belustine 40mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant oncology medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Cizumab 400mg Injection – Bevacizumab | Anti-Cancer Targeted Therapy | Global Supplier & Exporter Cizumab 400mg Injection contains Bevacizumab, a monoclonal antibody used in targeted cancer therapy. It works by blocking vascular endothelial growth factor (VEGF), a protein responsible for the formation of new blood vessels that supply nutrients to tumors. By inhibiting VEGF, Cizumab helps prevent tumor growth and slows the spread of cancer cells. Cizumab Injection is widely used in the treatment of several types of cancers including colorectal cancer, non-small cell lung cancer, ovarian cancer, cervical cancer, kidney cancer, and glioblastoma. It is often administered in combination with chemotherapy to enhance treatment effectiveness and improve patient outcomes. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Cizumab 400mg Injection to hospitals, oncology clinics, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Cizumab 400mg Injection Generic Name: Bevacizumab Strength: 400 mg Form: Injection / Vial Drug Class: Monoclonal Antibody (Anti-VEGF) Manufacturer: Hetero Healthcare Ltd. Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Cizumab contains Bevacizumab, which blocks VEGF (Vascular Endothelial Growth Factor). VEGF promotes the formation of new blood vessels that tumors require to grow and spread. By inhibiting VEGF, Cizumab prevents tumor angiogenesis and restricts tumor progression. Uses of Cizumab 400mg Injection Cizumab Injection is used in the treatment of: Metastatic Colorectal Cancer Non-Small Cell Lung Cancer (NSCLC) Ovarian Cancer Cervical Cancer Renal Cell Carcinoma (Kidney Cancer) Glioblastoma (Brain Tumor) Benefits Targeted anti-cancer therapy Prevents tumor blood vessel formation Slows cancer growth and spread Often used in combination with chemotherapy Improves treatment outcomes in advanced cancers Dosage & Administration Cizumab 400mg Injection is administered through intravenous infusion by a trained healthcare professional in a hospital or oncology center. The dosage and frequency depend on the patient’s condition, body weight, and prescribed treatment regimen. Possible Side Effects Some patients may experience: High blood pressure Nosebleeds Fatigue Protein in urine Headache Patients should be monitored during treatment to manage potential side effects. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and distributor of oncology and specialty medicines. We provide genuine pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Trusted oncology medicine exporter from India GMP certified pharmaceutical sourcing Competitive wholesale pricing Reliable global shipping (DHL / Aramex / FedEx) Export documentation, including COA, MSDS, invoice, and Packing List 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Reditux 500mg Injection – Rituximab | Lymphoma & Leukemia Treatment | Global Supplier & Exporter Reditux 500mg Injection contains Rituximab, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune disorders. It works by targeting the CD20 protein present on B-cells, allowing the immune system to destroy abnormal or cancerous B-cells. Reditux is widely used for the treatment of Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis. It may also be prescribed for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA). The medicine is typically administered in combination with chemotherapy or immunotherapy protocols to improve treatment effectiveness. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Reditux 500mg Injection to hospitals, oncology centers, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Reditux 500mg Injection Generic Name: Rituximab Strength: 500 mg Form: Injection / Vial Drug Class: Monoclonal Antibody Manufacturer: Dr. Reddy’s Laboratories Ltd. Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Reditux contains Rituximab, which is designed to target the CD20 antigen found on B-lymphocytes. By binding to CD20, it activates the immune system to destroy abnormal B-cells responsible for certain cancers and autoimmune diseases. This targeted therapy helps slow disease progression and improves treatment outcomes. Uses of Reditux 500mg Injection Reditux Injection is used in the treatment of: Non-Hodgkin’s Lymphoma Chronic Lymphocytic Leukemia (CLL) Rheumatoid Arthritis Granulomatosis with Polyangiitis Microscopic Polyangiitis Other B-cell related autoimmune disorders Benefits Targeted monoclonal antibody therapy Effective treatment for lymphoma and leukemia Helps control autoimmune immune-system disorders Used with chemotherapy for better outcomes Helps destroy abnormal B-cells in the body Dosage & Administration Reditux 500mg Injection is administered through intravenous infusion by a trained healthcare professional in a hospital or oncology clinic. The dosage and frequency depend on the patient’s medical condition, body weight, and treatment protocol. Possible Side Effects Some patients may experience: Fever or chills Infusion-related reactions Fatigue Low white blood cell count Headache or nausea Patients should be monitored closely during treatment. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and supplier of oncology and specialty medicines. We supply authentic pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Genuine oncology medicines GMP certified sourcing Competitive wholesale pricing Reliable worldwide shipping (DHL / Aramex / FedEx) Export documentation including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites. www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Mito-Med 2mg (Mitomycin) Injection – Global Supplier & Exporter | Ernest Oncology Mito-Med 2mg Mitomycin Injection—Chemotherapy Medicine for Bladder, Gastric & Pancreatic Cancer Mito-Med 2mg Injection (Mitomycin) is an effective anti-cancer chemotherapy medication used in the treatment of several types of cancers including bladder cancer, stomach cancer, pancreatic cancer, breast cancer, and gastrointestinal tumors. Mitomycin belongs to the class of medicines known as antitumor antibiotics, which work by preventing cancer cells from multiplying and spreading. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Mito-Med 2mg (Mitomycin) Injection to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica.What is Mito-Med 2 mg (Mitomycin) Injection? Mito-Med 2 mg contains Mitomycin, a potent chemotherapy drug originally derived from Streptomyces bacteria. It interferes with the DNA of cancer cells, preventing them from growing and dividing. Mitomycin has been widely used in oncology treatment protocols worldwide, especially for cancers affecting the gastrointestinal system and urinary bladder. Due to its strong anti-tumor activity, Mitomycin is often used alone or in combination with other chemotherapy agents.Mechanism of Action Mitomycin works by cross-linking DNA strands in cancer cells, preventing cellular replication. Key therapeutic actions include: • Blocking DNA synthesis in cancer cells • Preventing tumor cell division and proliferation • Interfering with cellular replication mechanisms • Inducing apoptosis (programmed cancer cell death) These mechanisms help slow the progression of solid tumors and malignant cancers. Medical Uses of Mito-Med 2 mg Injection Doctors prescribe Mito-Med (Mitomycin) for several cancer treatment protocols: Bladder Cancer Often used in intravesical chemotherapy for bladder cancer treatment. Gastric Cancer Used as part of chemotherapy regimens for stomach cancer. Pancreatic Cancer Helps slow the progression of advanced pancreatic cancer. Breast Cancer Sometimes used in combination therapy for metastatic breast cancer. Gastrointestinal Tumors Effective in treating certain GI cancers and malignant tumors. Benefits of Mito-Med 2 m (Mitomycin) Injection • Powerful chemotherapy medicine for various cancers • Helps slow tumor growth and disease progression • Effective for bladder and gastrointestinal cancers • Can be used in combination chemotherapy regimens • Recommended in international oncology treatment guidelines Product Information Product Name: Mito-Med Injection Generic Name: Mitomycin Strength: 2 mg Dosage Form: Injection / Lyophilized Powder Therapeutic Class: Anti-Cancer / Antitumor Antibiotic Indication: Bladder Cancer, Gastric Cancer, Pancreatic Cancer Prescription: Required Global Demand for Mitomycin Injection With the rising global incidence of gastrointestinal cancers and bladder cancer, the demand for Mitomycin chemotherapy injections continues to increase. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Mitomycin injections from trusted pharmaceutical exporters in India, such as Ernest Oncology. Mito-Med 2mg Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant oncology medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTIC PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Rituxirel 500mg Injection – Rituximab | Targeted Cancer & Autoimmune Therapy Supplier | Ernest Oncology Rituxirel 500mg Injection contains Rituximab, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune diseases. It works by targeting the CD20 protein found on B-cells, helping the immune system destroy abnormal or cancerous B-cells. Rituxirel is widely used in the treatment of Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis. It is commonly administered along with chemotherapy or other immunotherapy treatments to improve therapeutic outcomes. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Rituxirel 500mg Injection to hospitals, oncology centers, distributors, and pharmacies worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Rituxirel 500mg Injection Generic Name: Rituximab Strength: 500 mg Form: Injection / Vial Drug Class: Monoclonal Antibody Manufacturer: Reliance Life Sciences Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Rituxirel contains Rituximab, a monoclonal antibody that targets the CD20 antigen present on B-lymphocytes. By binding to CD20, Rituximab helps the immune system destroy abnormal or malignant B-cells, thereby reducing tumor growth and controlling autoimmune activity. Uses of Rituxirel 500mg Injection Rituxirel Injection is used for the treatment of: Non-Hodgkin’s Lymphoma Chronic Lymphocytic Leukemia (CLL) Rheumatoid Arthritis Granulomatosis with Polyangiitis (GPA) Microscopic Polyangiitis (MPA) Certain autoimmune disorders Benefits Targeted therapy for B-cell cancers Helps destroy abnormal immune cells Effective treatment for lymphoma and leukemia Used in combination with chemotherapy Improves clinical outcomes in autoimmune diseases Dosage & Administration Rituxirel 500mg Injection is administered by intravenous infusion under the supervision of a qualified healthcare professional in a hospital or oncology clinic. The dosage and treatment schedule depend on the patient’s condition, body weight, and medical history. Possible Side Effects Some patients may experience: Fever or chills Infusion reactions Nausea or fatigue Low blood cell counts Headache Patients should be monitored closely during treatment to manage potential side effects. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Global Export & Bulk Supply Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and distributor of oncology and specialty medicines. We provide authentic pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Trusted global pharmaceutical exporter from India GMP certified sourcing Competitive wholesale pricing Reliable international shipping (DHL / Aramex / FedEx) Export documentation including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Bevatas 400mg Injection – Bevacizumab | Anti-Cancer Targeted Therapy Supplier & Exporter | Ernest Oncology Bevatas 400mg Injection contains Bevacizumab, a monoclonal antibody used in targeted cancer therapy. It works by blocking vascular endothelial growth factor (VEGF), a protein responsible for the formation of new blood vessels that tumors need to grow. By inhibiting VEGF, Bevatas helps stop tumor growth and slows the spread of cancer. Bevatas Injection is commonly prescribed for the treatment of several types of cancers including colorectal cancer, lung cancer, ovarian cancer, cervical cancer, kidney cancer, and glioblastoma. It is often used in combination with chemotherapy to improve treatment outcomes. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Bevatas 400mg Injection to hospitals, oncology clinics, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Bevatas 400mg Injection Generic Name: Bevacizumab Strength: 400 mg Form: Injection / Vial Drug Class: Monoclonal Antibody (Anti-VEGF) Manufacturer: Intas Pharmaceuticals Ltd. Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Bevatas contains Bevacizumab, a targeted anti-cancer medicine that blocks VEGF (Vascular Endothelial Growth Factor). VEGF promotes the formation of new blood vessels that supply nutrients and oxygen to tumors. By inhibiting VEGF, Bevatas prevents tumor angiogenesis, restricting tumor growth and spread. Uses of Bevatas 400mg Injection Bevatas Injection is used in the treatment of: Metastatic Colorectal Cancer Non-Small Cell Lung Cancer (NSCLC) Ovarian Cancer Cervical Cancer Renal Cell Carcinoma (Kidney Cancer) Glioblastoma (Brain Tumor) Benefits Targeted anti-cancer therapy Inhibits tumor blood vessel formation Slows tumor growth and progression Used in combination with chemotherapy Improves treatment outcomes in advanced cancers Dosage & Administration Bevatas 400mg Injection is administered through intravenous infusion by a trained healthcare professional in a hospital or oncology clinic. The dosage depends on the patient’s condition, body weight, and treatment protocol. Possible Side Effects Some patients may experience: High blood pressure Nosebleeds Fatigue Protein in urine Headache Serious side effects are rare but medical monitoring is necessary during treatment. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Global Export & Bulk Supply Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and supplier of oncology medicines. We supply genuine pharmaceutical products with complete export documentation and fast international shipping. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Buy from Ernest Oncology? GMP certified pharmaceutical sourcing Competitive bulk and wholesale pricing Reliable global pharmaceutical exporter from India Fast worldwide delivery (DHL / Aramex / FedEx) Export documents including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Website www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Mito-Med 10mg (Mitomycin) Injection – Global Supplier & Exporter | Ernest Oncology Mito-Med 10mg Mitomycin Injection – Anti-Cancer Chemotherapy for Gastric, Pancreatic & Bladder Cancer Mito-Med 10mg Injection (Mitomycin) is a powerful chemotherapy medicine used in the treatment of several cancers, including gastric cancer, pancreatic cancer, breast cancer, bladder cancer, and certain gastrointestinal tumors. Mitomycin is classified as an antitumor antibiotic that works by preventing cancer cells from growing and dividing. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Mito-Med 10mg (Mitomycin) Injection to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major international healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Mito-Med 10mg (Mitomycin) Injection? Mito-Med 10mg contains Mitomycin, a cytotoxic chemotherapy drug derived from Streptomyces bacteria. It interferes with DNA synthesis in cancer cells, preventing them from multiplying. Mitomycin has been widely used in oncology treatment protocols worldwide, especially for cancers affecting the gastrointestinal tract and urinary bladder. Because of its potent anti-tumor activity, mitomycin is often used alone or in combination with other chemotherapy agents. Mechanism of Action Mitomycin works by cross-linking DNA strands inside cancer cells, preventing them from replicating. Its therapeutic actions include: • Blocking DNA synthesis in cancer cells • Preventing tumor cell division • Interfering with cellular replication mechanisms • Inducing apoptosis (programmed cancer cell death) These mechanisms help control the progression of various solid tumors and malignant cancers. Medical Uses of Mito-Med 10mg Injection Doctors prescribe Mito-Med (Mitomycin) for several cancer treatment protocols: Gastric Cancer Used in chemotherapy regimens for stomach cancer treatment. Pancreatic Cancer Helps slow progression of advanced pancreatic cancer. Bladder Cancer Commonly used in intravesical therapy for bladder cancer. Breast Cancer Sometimes used in combination chemotherapy for metastatic breast cancer. Gastrointestinal Tumors Effective in the treatment of certain GI cancers. Benefits of Mito-Med 10mg (Mitomycin) Injection • Potent chemotherapy agent for multiple cancers • Helps slow tumor growth and cancer progression • Effective for gastrointestinal and bladder cancers • Can be used in combination chemotherapy regimens • Recommended in international oncology treatment guidelines Product Information Strength: 10 mg Dosage Form: Injection / Lyophilized Powder Therapeutic Class: Anti-Cancer / Antitumor Antibiotic Indication: Gastric Cancer, Pancreatic Cancer, Bladder Cancer, Breast Cancer Prescription: Required Global Demand for Mitomycin Injection The increasing global burden of gastrointestinal and bladder cancers has significantly increased demand for Mitomycin chemotherapy injections. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Mitomycin injections from trusted pharmaceutical exporters in India, such as Ernest Oncology. Mito-Med 10mg Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant oncology medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383